United Therapeutics (UTHR) announced that ten posters and presentations across its commercial and development portfolio will be presented at ...

Drug developers will now have enhanced abilities to rapidly prototype, test, iterate, and scale up their mRNA therapeutics.

Key to 400-employee Denali's submission is the FDA allowing measurement of a type of GAG, called heparan sulfate, in ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

As usual, one of the easiest ways to amass a large chunk of rewards is through credit card welcome bonuses. United loyalists are in luck because Chase and United have teamed up to offer best-ever ...

The decision came after the discovery of a problem with the methodology used in these data sets. The issue impacts data from the year 2008 onward, but the most significant effect on annual producer ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Plus Therapeutics shares are trading higher by 244% during Thursday's session. The company announced that the FDA accepted the name REYOBIQ for the company's lead asset. The ‘Trade of the Day ...

BofA lowered the firm’s price target on United Therapeutics (UTHR) to $314 from $328 and keeps an Underperform rating on the shares. The firm thinks the challenges to owning United in 2025 are ...

The company will henceforth be known as Whitehawk Therapeutics, it announced Tuesday. Its stock ticker will be updated accordingly: As of Wednesday, it will trade as “WHWK” on the Nasdaq ...

LAVAL, Quebec — Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its ...

The newly approved trial, led by United Therapeutics, a biotechnology firm based in Maryland and North Carolina, will test xenotransplantation's potential. Initially enrolling six people with end ...